Hola,
Are you new here?

AmReSu

financed

Enhanced Networking on Antimicrobial Resistance Surveillance with Next Generatio...

Enhanced Networking on Antimicrobial Resistance Surveillance with Next Generation Sequencing Our project Enhanced networking on antimicrobial resistance surveillance with NGS brings together Semmelweis University (SU) and Klinika Za Infektivne Bolesti „Dr. Fran Mihaljevic (BFM) with two internationally leading research in... see more

31/03/2024

SEMMELWEIS UNIVERS...

900K€

Project Budget: 900K€

Project leader

SEMMELWEIS EGYETEM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 5 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2024-03-31

WIDESPREAD-05-2020: Twinning Specific Challenge:The specific challenge is to enhance networking activities between the research i...

I+D

Cerrada does 5 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

SEMMELWEIS UNIVERSITY

264.83K€ | Leader

FUCHO SOCIEDAD LIMITADA

354.68K€ | participant

KIB

173.93K€ | participant

UANTWERPEN

310.88K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 44 months Date Start: 2020-07-06
End date: 2024-03-31

Project leader

SEMMELWEIS EGYETEM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 900K€

participation deadline Sin fecha límite de participación.

Project description Our project Enhanced networking on antimicrobial resistance surveillance with NGS brings together Semmelweis University (SU) and Klinika Za Infektivne Bolesti „Dr. Fran Mihaljevic (BFM) with two internationally leading research institutions, Laboratory of Medical Microbiology (LMM), University of Antwerp (UAntwerp) and the Health Research Institute of the Balearic Islands (IdISBa) , on the topic of Antimicrobial resistance surveillance with whole genome sequencing (WGS) in correlation next-generation sequencing techniques. Our aim in AmReSu is to strengthen, to the highest European level, Semmelweis University (SU)’s and Klinika Za Infektivne Bolesti „Dr. Fran Mihaljevic (BFM)’s scientific excellence and innovation capacity in Antimicrobial resistance surveillance and to set-up an ‘Antimicrobial resistance surveillance vision’ in Hungary and Croatia. Strenghtening antimicrobial resistance (AMR) surveillance is also in line with the Hungarian National Smart Specialisation Strategy and the Croatian National Programe for Antibiotic Resistance Control. AMR bacterial infections are a global threat, they are responsible for increased morbidity and mortality rates in Hungary and Croatia, especially in cases of nosocomial infection. Many previously manageable bacterial infections are becoming increasingly hard to treat. Rising rates of resistance amplify the morbidity and economic burden associated with infections. An estimated 700,000 deaths attributable to AMR every year in the world, and a projected 10 million deaths per year by 2050 in the absence of additional control measures. The core activities of our project are knowledge transfer, exchanges of best practices via a number of institutional networking and training activities, including workshops, conferences, summer schools. to a new level, promoting research excellence in AMR and Microbiome with strong societal impact. Our proposed actions will strengthen joint research programmes in Europe.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers